kim yoon jun - Search Results

Year	Number of Results
2003	8
2005	4
2006	5
2007	10
2008	5
2009	9
2010	15
2011	22
2012	17
2013	22
2014	30
2015	42
2016	30
2017	31
2018	34
2019	25
2020	31
2021	34
2022	24
2023	36
2024	13

1

No-Touch Radiofrequency Ablation Using Twin Cooled Wet Electrodes for Recurrent Hepatocellular Carcinoma Following Locoregional Treatments.

Hong SJ, Kim JH, Yoon JH, Park JH, Yoon JH, Kim YJ, Yu SJ, Cho EJ, Lee JM. Hong SJ, et al. Among authors: kim yj. Korean J Radiol. 2024 May;25(5):438-448. doi: 10.3348/kjr.2023.1225. Korean J Radiol. 2024. PMID: 38685734 Free PMC article.

2

Gamma-glutamyl transferase and the risk of all-cause and disease-specific mortality in patients with diabetes: A nationwide cohort study.

Chung GE, Jeong SM, Yu SJ, Yoo JJ, Cho Y, Lee KN, Shin DW, Kim YJ, Yoon JH, Han K, Cho EJ. Chung GE, et al. Among authors: kim yj. J Diabetes. 2024 May;16(5):e13551. doi: 10.1111/1753-0407.13551. J Diabetes. 2024. PMID: 38664890 Free PMC article.

3

Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy.

Yim HJ, Kang SH, Jung YK, Ahn SH, Kim W, Yang JM, Jang JY, Kweon YO, Cho YK, Kim YJ, Hong GY, Kim DJ, Sohn JH, Lee JW, Park SJ, Yim SY, Park JK, Um SH. Yim HJ, et al. Among authors: kim yj. Cancers (Basel). 2024 Feb 22;16(5):887. doi: 10.3390/cancers16050887. Cancers (Basel). 2024. PMID: 38473248 Free PMC article.

4

Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study.

Chung SW, Moon HS, Shin H, Han H, Park S, Cho H, Park J, Hur MH, Park MK, Won SH, Lee YB, Cho EJ, Yu SJ, Kim DK, Yoon JH, Lee JH, Kim YJ. Chung SW, et al. Among authors: kim yj. Hepatology. 2024 Mar 11. doi: 10.1097/HEP.0000000000000837. Online ahead of print. Hepatology. 2024. PMID: 38466796

5

High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study.

Yoon JS, Hong JH, Park SY, Kim SU, Kim HY, Kim JY, Hur MH, Park MK, Lee YB, Lee HA, Kim GA, Sinn DH, Park SJ, Lee YJ, Kim YJ, Yoon JH, Lee JH. Yoon JS, et al. Among authors: kim yj. Aliment Pharmacol Ther. 2024 Apr;59(8):973-983. doi: 10.1111/apt.17909. Epub 2024 Feb 22. Aliment Pharmacol Ther. 2024. PMID: 38389319

6

A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.

Hirschfield GM, Bowlus CL, Mayo MJ, Kremer AE, Vierling JM, Kowdley KV, Levy C, Villamil A, Ladrón de Guevara Cetina AL, Janczewska E, Zigmond E, Jeong SH, Yilmaz Y, Kallis Y, Corpechot C, Buggisch P, Invernizzi P, Londoño Hurtado MC, Bergheanu S, Yang K, Choi YJ, Crittenden DB, McWherter CA; RESPONSE Study Group. Hirschfield GM, et al. N Engl J Med. 2024 Feb 29;390(9):783-794. doi: 10.1056/NEJMoa2312100. Epub 2024 Feb 21. N Engl J Med. 2024. PMID: 38381664 Clinical Trial.

7

Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort study.

Shin H, Kim SU, Song BG, Park Y, Ko Y, Park J, Hur MH, Lee YB, Cho EJ, Lee JH, Yu SJ, Yoon JH, Sinn DH, Kim YJ. Shin H, et al. Among authors: kim yj. Hepatol Res. 2024 Feb 1. doi: 10.1111/hepr.14021. Online ahead of print. Hepatol Res. 2024. PMID: 38300711

8

Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection.

Janssen HL, Lim YS, Kim HJ, Sowah L, Tseng CH, Coffin CS, Elkhashab M, Ahn SH, Nguyen AH, Chen D, Wallin JJ, Fletcher SP, McDonald C, Yang JC, Gaggar A, Brainard DM, Fung S, Kim YJ, Kao JH, Chuang WL, Brooks AE, Dunbar PR. Janssen HL, et al. Among authors: kim yj. JHEP Rep. 2023 Nov 30;6(2):100975. doi: 10.1016/j.jhepr.2023.100975. eCollection 2024 Feb. JHEP Rep. 2023. PMID: 38274492 Free PMC article.

9

Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis.

Park J, Lee YB, Ko Y, Park Y, Shin H, Hur MH, Park MK, Lee DW, Cho EJ, Lee KH, Lee JH, Yu SJ, Kim TY, Kim YJ, Kim TY, Yoon JH. Park J, et al. Among authors: kim yj. J Liver Cancer. 2024 Mar;24(1):81-91. doi: 10.17998/jlc.2023.12.25. Epub 2024 Jan 19. J Liver Cancer. 2024. PMID: 38246747 Free PMC article.

10

Extrahepatic malignancies in metabolic dysfunction-associated fatty liver disease: A nationwide cohort study.

Park MK, Hur MH, Moon HS, Shin H, Chung SW, Won S, Lee YB, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ. Park MK, et al. Among authors: kim yj. Liver Int. 2024 Mar;44(3):799-810. doi: 10.1111/liv.15832. Epub 2024 Jan 17. Liver Int. 2024. PMID: 38230848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

389 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

389 results

Results by year